Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Risk reducing surgery with peritoneal staging in BRCA1-2 mutation carriers. A prospective study.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology - 1 Dec 2022

Marchetti Claudia, Arcieri Martina, Vertechy Laura, Ergasti Raffaella, Russo Giorgia, Zannoni Gian Franco, Minucci Angelo, Ercoli Alfredo, Scambia Giovanni, Fagotti Anna

Abstract excerpt

INTRODUCTION: International guidelines recommend risk-reducing salpingo-oophorectomy (RRSO) in BRCA1-2 mutations carriers to decrease ovarian cancer occurrence. In this prospective study, we describe the incidence of occult malignancies and the surgical outcomes in asymptomatic BRCA mutation carriers submitted to RRSO. METHODS: Data on BRCA1-2 carriers undergoing RRSO with peritoneal washing and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA1 Protein
Share to Carcinoma

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Fallopian Tube Neoplasms

Share to Genes, BRCA1

Share to Genes, BRCA2

Share to Neoplasms, Unknown Primary

Share to Ovarian Neoplasms

Share to Ovariectomy

Source

Identifiers

PMID: 35871032
DOI: 10.1016/j.ejso.2022.07.007

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Risk reducing surgery with peritoneal staging in BRCA1-2 mutation carriers. A prospective study.PMID 35871032Read ↗

Clinical significance of risk-reducing salpingo-oophorectomy in patients with BRCA1/2 mutation.Semantic proximity Read ↗

Peritoneal cancer risk after risk reducing salpingo-oophorectomy, impact of mutational status and STIC lesions.Semantic proximity Read ↗

Pathologic findings and clinical outcomes in women undergoing risk-reducing surgery to prevent ovarian and fallopian tube carcinoma: A large prospective single institution experience.Semantic proximity Read ↗

Specialist oncological surgery for removal of the ovaries and fallopian tubes in BRCA1 and BRCA2 pathogenic variant carriers may reduce primary peritoneal cancer risk to very low levels.Semantic proximity Read ↗

Clinical and pathological outcomes of risk-reducing salpingo-oophorectomy for Japanese women with hereditary breast and ovarian cancer.Semantic proximity Read ↗

Efficacy of risk-reducing salpingo-oophorectomy in BRCA1-2 variants and clinical outcomes of follow-up in patients with isolated serous tubal intraepithelial carcinoma (STIC).Semantic proximity Read ↗

Peritoneal carcinomatosis after risk-reducing surgery in BRCA1/2 mutation carriers.Semantic proximity Read ↗

Pathological findings and long-term prognosis in Korean BRCA1/2 mutation carriers undergoing risk-reducing salpingo-oophorectomy.Semantic proximity Read ↗

Risk-reducing salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers.Semantic proximity Read ↗

Occult and subsequent cancer incidence following risk-reducing surgery in BRCA mutation carriers.Semantic proximity Read ↗

High-Grade Serous Carcinoma at Risk-Reducing Salpingo-Oophorectomy in Asymptomatic Carriers of BRCA1/2 Pathogenic Variants: Prevalence and Clinical Factors.Semantic proximity Read ↗

Risk-reducing salpingo-oophorectomy (RRSO) in BRCA mutation carriers: experience with a consecutive series of 111 patients using a standardized surgical-pathological protocol.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.